CORE EARNINGS PER SHARE: Core earnings per share are expected to rise to $2.07 from $1.45 the year prior, according to the same consensus. AstraZeneca's stock is up 7.9% since the start of 2024.

Palantir's U.S. commercial revenue surged 64% YoY, driven by AIP technology, but faces intensifying competition and high ...

PepsiCo Inc. (NASDAQ:PEP) reported its fourth-quarter 2024 earnings with an earnings per share (EPS) of $1.96, slightly above ...

Pfizer reported robust fourth-quarter 2024 earnings, exceeding expectations in both revenue and adjusted earnings.

Pro Medicus is in a strong financial position. As of June 2024, it had AUD 155 million in net cash, and we forecast the company to continue holding net cash over our explicit 10-year forecast period.

Home energy technology company Enphase (NASDAQ:ENPH) will be reporting earnings tomorrow after market hours. Here’s what ...

Synopsys' strong financial performance underscores its robust business fundamentals. See why I reiterate my buy rating for ...

Sustained economic growth hinges on bolstering employment incomes, which directly fuel consumer spending, spurring investment ...

Novartis reported strong Q4 earnings and sales growth, with CEO Narasimhan reportedly downplaying concerns over Entresto's ...

Meritage Homes Corporation (NYSE: MTH), a leading U.S. homebuilder, today announced fourth quarter and full year results for the periods ended December ...

Reports Q2 revenue $4.7B, consensus $4.8B. “Our performance this quarter reflects our focus on operational excellence and the strength of our ...

We recently compiled a list of the 15 Best Monthly Dividend Stocks To Buy Right Now. In this article, we are going to take a ...